A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

NCT01152554 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

813

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder
MDD
Depression

Interventions

DRUG: TC-5214
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]